Join us for this Thought Leaders episode as Prof. Saad Nadeem from Memorial Sloan Kettering Cancer Center explains how DeepLIIF and the DP4all (Digital Pathology for All) initiative are opening up new possibilities for digital pathology — from major cancer centres to small community labs and low-resource settings around the world.PresentersHosted by Jonathan Tunstall, CEO and Founder of Pathology News, this Thought Leaders episode features an exclusive interview with:Prof. Saad Nadeem, Computational Pathology & Medical Image Analysis, Memorial Sloan Kettering Cancer CenterIn this Thought Leaders conversation, we explore how Saad’s background in computer science, mathematics and medical image analysis led him from radiology into computational pathology, and why he views radiology, surgery and pathology as a single continuum along the patient journey.We discuss the development of DeepLIIF (Deep Learning Inferred Immunofluorescence) as a virtual re-stain method that can extend the dynamic range of IHC, improve cell and compartment segmentation, and provide a stronger foundation for robust biomarker quantification. Saad explains how this work underpins a broader push toward more objective, reproducible companion diagnostics.A major focus of the episode is DP4all, Mind’s “digital pathology for all” initiative, which uses a simple smartphone-plus-microscope workflow to generate shareable, cloud-hosted whole slide images without dedicated scanners or storage infrastructure. We examine how this approach can support telepathology, virtual tumour boards and second opinions in both low- and high-resource settings, and why many donated scanners in low-resource regions currently sit idle.We also touch on the CAP AI Playground collaboration with PathPresenter, designed to give pathologists transparent, hands-on access to AI tools without paywalls, and discuss the realities of regulation, validation and reimbursement for clinical deployment.With a frank discussion on whether digitisation is truly “inevitable,” and how accessible tools like DeepLIIF and DP4all could shift the economics and equity of digital pathology, this episode offers a compelling vision of how computational methods can support clinicians and patients far beyond the walls of major academic centres.

In this episode of Pathology News Talks, we sit down with Ben Cahoon, CEO of Techcyte, one of the most innovative leaders in the digital pathology space.

Ben shares the journey from his early days at Intel to building Techcyte — a company redefining pathology through the Fusion Platform, which unites anatomic and clinical pathology in a single workflow.

We dive into:

💡 How Techcyte evolved from environmental and veterinary labs to human clinical and anatomic pathology

🧬 The power of combining AI, workflow, and data integration

🔬 The path to true multimodal pathology — merging digital slides, molecular data, and patient history

⚙️ What “scanner agnostic” really means and why DICOM compliance is key

🧠 Why the future of diagnostics isn’t AI versus humans, but AI with humans

Whether you’re in pathology, informatics, or digital health, this one’s packed with insights on where our industry is heading and how software platforms like Fusion are accelerating that shift.

Captured live on 19th October 2025 at ESMO in Berlin, this Pathology News special with Felix Faber and Dr. Patrick Frey explores how multiplex immunofluorescence, paired with AI and foundation models, is enabling deeper insight into spatial biology, biomarker validation, and the evolving role of diagnostics in cancer care.

For more on Mindpeak, head over to Pathology News.

In this episode of Pathology News Talks, we sit down with Andy Beck, Co-Founder and CEO of PathAI, to explore the transformation of pathology through artificial intelligence.

Andy shares his journey from academia to building one of the most influential companies in digital pathology, reflects on the challenges of regulation and adoption, and discusses PathAI’s recent FDA clearance for its AISight DX platform. We also dive into collaborations with Roche and leading medical centres, the rise of digital biomarkers, and what the future of AI-powered pathology might look like in the next decade.

If you want to understand how digital pathology, AI, and clinical workflows are converging to shape the future of diagnostics, this episode is for you.

Hosted by Jonathan Tunstall, CEO & Founder of Pathology News, this episode features:Katerina von Loga, Head of Pathology at Owkin.

With a unique background in academic pathology and AI-driven diagnostics, Katerina shares how her journey from multiplex immunofluorescence to working with cutting-edge weakly supervised models shaped her perspective on the role of artificial intelligence in modern pathology.

In this wide-ranging conversation, we explore:

• Why AI is strengthening the business case for digital pathology

• How Owkin’s models are uncovering novel biological insights

• The path toward interpretability, regulatory trust, and integration in clinical workflows

• Key products like the MSIntuit model for colorectal cancer and Owkin’s relapse prediction tools

• The long-term vision for multimodal AI in pathology.

We also touch on the State of the Nation and From Slide to Device white papers, offering insight into adoption trends, clinical barriers, and the future role of the pathologist.

State of the Nation - https://www.owkin.com/connect/state-of-the-nation

From Slide to Device - https://www.owkin.com/connect/slide-to-device

📍 Don’t miss this deep dive into the evolving world of diagnostic AI and the future of digital pathology. 🔔 Like, comment, and subscribe for more episodes of Pathology Talks.

#DigitalPathology #AIinHealthcare #Owkin #PathologyNews #MultimodalAI #MSIntuit

🎙️ Hosted by Jonathan Tunstall, CEO & Founder of Pathology News, this Thought Leaders episode features:

🔹 Prasanth Perugupalli, Chief Product Officer at Pramana

With a background in electrical engineering and over 20 years of experience in imaging and product innovation, Prasanth shares how Pramana is reimagining digital pathology. From modular scanner architecture and built-in quality assurance to AI-powered, autonomous imaging, he lays out a clear vision for the future of pathology labs.

We also explore the rise of digitally-native pathologists, the role of AI in diagnostic workflows, and how Pramana is gearing up for European expansion in 2025.

📍 If you’re curious about the future of lab tech and smart imaging, this is a must-listen.

🔔 Like, comment, and subscribe for more Pathology Talks: Thought Leaders episodes.

#DigitalPathology #AIinHealthcare #Pramana #PathologyNews #ThoughtLeaders #LabInnovation

What happened in DP&AI in the last two weeks... let’s get into it!

🚀 Join us for an exclusive interview with Joe Yeh, Co-founder, CEO, and Chairman of aetherAI, as we explore how AI is revolutionizing digital pathology. From groundbreaking “True Gigapixel” technology to AI-powered diagnostics, Joe shares insights on industry challenges, regulatory hurdles, and the future of pathology.

📍 Learn how aetherAI is integrating AI into pathology workflows, collaborating with global healthcare institutions, and pushing the boundaries of medical AI innovation.

🔬 Don’t miss this deep dive into the future of digital pathology!

📢 Catch aetherAI at USCAP 2025 (Booth 229) in Boston from March 22-27!

🔔 Like, comment, and subscribe for more cutting-edge pathology news! #DigitalPathology #AIinHealthcare #PathologyNews